COVID-19 Impact on Global Implantable Drug-Eluting Devices Market Insights, Forecast to 2026

Published: June 2020

No. of Pages: 114

Price:

Single User License: US $ 4900 US $ 3675
Corporate User License: US $ 9800 US $ 7350

Report Description
Table of Contents

Implantable Drug-Eluting Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Implantable Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Implantable Drug-Eluting Devices market is segmented into

Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others

Segment by Application, the Implantable Drug-Eluting Devices market is segmented into

Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others

Regional and Country-level Analysis
The Implantable Drug-Eluting Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Implantable Drug-Eluting Devices market report are North America, Europe and China. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Implantable Drug-Eluting Devices Market Share Analysis

Implantable Drug-Eluting Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Implantable Drug-Eluting Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Implantable Drug-Eluting Devices business, the date to enter into the Implantable Drug-Eluting Devices market, Implantable Drug-Eluting Devices product introduction, recent developments, etc.

The major vendors covered:

Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals, Inc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical

Table of Contents

1 Study Coverage
1.1 Implantable Drug-Eluting Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Implantable Drug-Eluting Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Implantable Drug-Eluting Devices Market Size Growth Rate by Type
1.4.2 Implantable Drug Infusion Pumps
1.4.3 Intraocular Drug-Eluting Devices
1.4.4 Contraceptive Drug-Eluting Devices
1.4.5 Drug-Eluting Stents
1.4.6 Others
1.5 Market by Application
1.5.1 Global Implantable Drug-Eluting Devices Market Size Growth Rate by Application
1.5.2 Diabetes
1.5.3 Contraception
1.5.4 HIV/AIDS Prevention
1.5.5 Chronic Pain Management
1.5.6 Cardiovascular
1.5.7 Ophthalmology
1.5.8 Oncology
1.5.9 Others
1.6 Coronavirus Disease 2019 (Covid-19): Implantable Drug-Eluting Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Implantable Drug-Eluting Devices Industry
1.6.1.1 Implantable Drug-Eluting Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Implantable Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Implantable Drug-Eluting Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Implantable Drug-Eluting Devices Market Size Estimates and Forecasts
2.1.1 Global Implantable Drug-Eluting Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Implantable Drug-Eluting Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Implantable Drug-Eluting Devices Production Estimates and Forecasts 2015-2026
2.2 Global Implantable Drug-Eluting Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Implantable Drug-Eluting Devices Manufacturers Geographical Distribution
2.4 Key Trends for Implantable Drug-Eluting Devices Markets & Products
2.5 Primary Interviews with Key Implantable Drug-Eluting Devices Players (Opinion Leaders)

3 Market Size by Manufacturers
3.1 Global Top Implantable Drug-Eluting Devices Manufacturers by Production Capacity
3.1.1 Global Top Implantable Drug-Eluting Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Implantable Drug-Eluting Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Implantable Drug-Eluting Devices Manufacturers Market Share by Production
3.2 Global Top Implantable Drug-Eluting Devices Manufacturers by Revenue
3.2.1 Global Top Implantable Drug-Eluting Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Implantable Drug-Eluting Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Implantable Drug-Eluting Devices Revenue in 2019
3.3 Global Implantable Drug-Eluting Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 Implantable Drug-Eluting Devices Production by Regions
4.1 Global Implantable Drug-Eluting Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Implantable Drug-Eluting Devices Regions by Production (2015-2020)
4.1.2 Global Top Implantable Drug-Eluting Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Implantable Drug-Eluting Devices Production (2015-2020)
4.2.2 North America Implantable Drug-Eluting Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Implantable Drug-Eluting Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Implantable Drug-Eluting Devices Production (2015-2020)
4.3.2 Europe Implantable Drug-Eluting Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Implantable Drug-Eluting Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Implantable Drug-Eluting Devices Production (2015-2020)
4.4.2 China Implantable Drug-Eluting Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Implantable Drug-Eluting Devices Import & Export (2015-2020)

5 Implantable Drug-Eluting Devices Consumption by Region
5.1 Global Top Implantable Drug-Eluting Devices Regions by Consumption
5.1.1 Global Top Implantable Drug-Eluting Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Implantable Drug-Eluting Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Implantable Drug-Eluting Devices Consumption by Application
5.2.2 North America Implantable Drug-Eluting Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Implantable Drug-Eluting Devices Consumption by Application
5.3.2 Europe Implantable Drug-Eluting Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Implantable Drug-Eluting Devices Consumption by Application
5.4.2 Asia Pacific Implantable Drug-Eluting Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Implantable Drug-Eluting Devices Consumption by Application
5.5.2 Central & South America Implantable Drug-Eluting Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Implantable Drug-Eluting Devices Consumption by Application
5.6.2 Middle East and Africa Implantable Drug-Eluting Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E

6 Market Size by Type (2015-2026)
6.1 Global Implantable Drug-Eluting Devices Market Size by Type (2015-2020)
6.1.1 Global Implantable Drug-Eluting Devices Production by Type (2015-2020)
6.1.2 Global Implantable Drug-Eluting Devices Revenue by Type (2015-2020)
6.1.3 Implantable Drug-Eluting Devices Price by Type (2015-2020)
6.2 Global Implantable Drug-Eluting Devices Market Forecast by Type (2021-2026)
6.2.1 Global Implantable Drug-Eluting Devices Production Forecast by Type (2021-2026)
6.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Type (2021-2026)
6.3 Global Implantable Drug-Eluting Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)
7.2.1 Global Implantable Drug-Eluting Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Implantable Drug-Eluting Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles
8.1 Pfizer
8.1.1 Pfizer Corporation Information
8.1.2 Pfizer Overview and Its Total Revenue
8.1.3 Pfizer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Pfizer Product Description
8.1.5 Pfizer Recent Development
8.2 Medtronic
8.2.1 Medtronic Corporation Information
8.2.2 Medtronic Overview and Its Total Revenue
8.2.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Medtronic Product Description
8.2.5 Medtronic Recent Development
8.3 Merck
8.3.1 Merck Corporation Information
8.3.2 Merck Overview and Its Total Revenue
8.3.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Merck Product Description
8.3.5 Merck Recent Development
8.4 Bayer AG
8.4.1 Bayer AG Corporation Information
8.4.2 Bayer AG Overview and Its Total Revenue
8.4.3 Bayer AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Bayer AG Product Description
8.4.5 Bayer AG Recent Development
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Corporation Information
8.5.2 Johnson & Johnson Overview and Its Total Revenue
8.5.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Johnson & Johnson Product Description
8.5.5 Johnson & Johnson Recent Development
8.6 Abbott
8.6.1 Abbott Corporation Information
8.6.2 Abbott Overview and Its Total Revenue
8.6.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Abbott Product Description
8.6.5 Abbott Recent Development
8.7 Surmodics
8.7.1 Surmodics Corporation Information
8.7.2 Surmodics Overview and Its Total Revenue
8.7.3 Surmodics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Surmodics Product Description
8.7.5 Surmodics Recent Development
8.8 Boston Scientific Corporation
8.8.1 Boston Scientific Corporation Corporation Information
8.8.2 Boston Scientific Corporation Overview and Its Total Revenue
8.8.3 Boston Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Boston Scientific Corporation Product Description
8.8.5 Boston Scientific Corporation Recent Development
8.9 Titan Pharmaceuticals, Inc.
8.9.1 Titan Pharmaceuticals, Inc. Corporation Information
8.9.2 Titan Pharmaceuticals, Inc. Overview and Its Total Revenue
8.9.3 Titan Pharmaceuticals, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Titan Pharmaceuticals, Inc. Product Description
8.9.5 Titan Pharmaceuticals, Inc. Recent Development
8.10 BIOTRONIK
8.10.1 BIOTRONIK Corporation Information
8.10.2 BIOTRONIK Overview and Its Total Revenue
8.10.3 BIOTRONIK Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 BIOTRONIK Product Description
8.10.5 BIOTRONIK Recent Development
8.11 Allergan
8.11.1 Allergan Corporation Information
8.11.2 Allergan Overview and Its Total Revenue
8.11.3 Allergan Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Allergan Product Description
8.11.5 Allergan Recent Development
8.12 Bausch & Lomb
8.12.1 Bausch & Lomb Corporation Information
8.12.2 Bausch & Lomb Overview and Its Total Revenue
8.12.3 Bausch & Lomb Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Bausch & Lomb Product Description
8.12.5 Bausch & Lomb Recent Development
8.13 REVA Medical
8.13.1 REVA Medical Corporation Information
8.13.2 REVA Medical Overview and Its Total Revenue
8.13.3 REVA Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 REVA Medical Product Description
8.13.5 REVA Medical Recent Development
8.14 MicroPort Medical
8.14.1 MicroPort Medical Corporation Information
8.14.2 MicroPort Medical Overview and Its Total Revenue
8.14.3 MicroPort Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 MicroPort Medical Product Description
8.14.5 MicroPort Medical Recent Development

9 Production Forecasts by Regions
9.1 Global Top Implantable Drug-Eluting Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Implantable Drug-Eluting Devices Regions Forecast by Production (2021-2026)
9.3 Key Implantable Drug-Eluting Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China

10 Implantable Drug-Eluting Devices Consumption Forecast by Region
10.1 Global Implantable Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.2 North America Implantable Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Implantable Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Implantable Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Implantable Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Implantable Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Implantable Drug-Eluting Devices Sales Channels
11.2.2 Implantable Drug-Eluting Devices Distributors
11.3 Implantable Drug-Eluting Devices Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Implantable Drug-Eluting Devices Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Tables

Table 1. Implantable Drug-Eluting Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Implantable Drug-Eluting Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Implantable Drug-Eluting Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Implantable Drug Infusion Pumps
Table 5. Major Manufacturers of Intraocular Drug-Eluting Devices
Table 6. Major Manufacturers of Contraceptive Drug-Eluting Devices
Table 7. Major Manufacturers of Drug-Eluting Stents
Table 8. Major Manufacturers of Others
Table 9. COVID-19 Impact Global Market: (Four Implantable Drug-Eluting Devices Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Implantable Drug-Eluting Devices Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Implantable Drug-Eluting Devices Players to Combat Covid-19 Impact
Table 14. Global Implantable Drug-Eluting Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 15. Global Implantable Drug-Eluting Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Implantable Drug-Eluting Devices as of 2019)
Table 18. Implantable Drug-Eluting Devices Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Implantable Drug-Eluting Devices Product Offered
Table 20. Date of Manufacturers Enter into Implantable Drug-Eluting Devices Market
Table 21. Key Trends for Implantable Drug-Eluting Devices Markets & Products
Table 22. Main Points Interviewed from Key Implantable Drug-Eluting Devices Players
Table 23. Global Implantable Drug-Eluting Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 24. Global Implantable Drug-Eluting Devices Production Share by Manufacturers (2015-2020)
Table 25. Implantable Drug-Eluting Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 26. Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2015-2020)
Table 27. Implantable Drug-Eluting Devices Price by Manufacturers 2015-2020 (USD/Unit)
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Implantable Drug-Eluting Devices Production by Regions (2015-2020) (K Units)
Table 30. Global Implantable Drug-Eluting Devices Production Market Share by Regions (2015-2020)
Table 31. Global Implantable Drug-Eluting Devices Revenue by Regions (2015-2020) (US$ Million)
Table 32. Global Implantable Drug-Eluting Devices Revenue Market Share by Regions (2015-2020)
Table 33. Key Implantable Drug-Eluting Devices Players in North America
Table 34. Import & Export of Implantable Drug-Eluting Devices in North America (K Units)
Table 35. Key Implantable Drug-Eluting Devices Players in Europe
Table 36. Import & Export of Implantable Drug-Eluting Devices in Europe (K Units)
Table 37. Key Implantable Drug-Eluting Devices Players in China
Table 38. Import & Export of Implantable Drug-Eluting Devices in China (K Units)
Table 39. Global Implantable Drug-Eluting Devices Consumption by Regions (2015-2020) (K Units)
Table 40. Global Implantable Drug-Eluting Devices Consumption Market Share by Regions (2015-2020)
Table 41. North America Implantable Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 42. North America Implantable Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Implantable Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 44. Europe Implantable Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Implantable Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Implantable Drug-Eluting Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Implantable Drug-Eluting Devices Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Implantable Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Implantable Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Implantable Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Implantable Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 52. Global Implantable Drug-Eluting Devices Production by Type (2015-2020) (K Units)
Table 53. Global Implantable Drug-Eluting Devices Production Share by Type (2015-2020)
Table 54. Global Implantable Drug-Eluting Devices Revenue by Type (2015-2020) (Million US$)
Table 55. Global Implantable Drug-Eluting Devices Revenue Share by Type (2015-2020)
Table 56. Implantable Drug-Eluting Devices Price by Type 2015-2020 (USD/Unit)
Table 57. Global Implantable Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 58. Global Implantable Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)
Table 59. Global Implantable Drug-Eluting Devices Consumption Share by Application (2015-2020)
Table 60. Pfizer Corporation Information
Table 61. Pfizer Description and Major Businesses
Table 62. Pfizer Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Pfizer Product
Table 64. Pfizer Recent Development
Table 65. Medtronic Corporation Information
Table 66. Medtronic Description and Major Businesses
Table 67. Medtronic Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Medtronic Product
Table 69. Medtronic Recent Development
Table 70. Merck Corporation Information
Table 71. Merck Description and Major Businesses
Table 72. Merck Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Merck Product
Table 74. Merck Recent Development
Table 75. Bayer AG Corporation Information
Table 76. Bayer AG Description and Major Businesses
Table 77. Bayer AG Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bayer AG Product
Table 79. Bayer AG Recent Development
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Major Businesses
Table 82. Johnson & Johnson Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Recent Development
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Major Businesses
Table 87. Abbott Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Abbott Product
Table 89. Abbott Recent Development
Table 90. Surmodics Corporation Information
Table 91. Surmodics Description and Major Businesses
Table 92. Surmodics Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Surmodics Product
Table 94. Surmodics Recent Development
Table 95. Boston Scientific Corporation Corporation Information
Table 96. Boston Scientific Corporation Description and Major Businesses
Table 97. Boston Scientific Corporation Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Boston Scientific Corporation Product
Table 99. Boston Scientific Corporation Recent Development
Table 100. Titan Pharmaceuticals, Inc. Corporation Information
Table 101. Titan Pharmaceuticals, Inc. Description and Major Businesses
Table 102. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Titan Pharmaceuticals, Inc. Product
Table 104. Titan Pharmaceuticals, Inc. Recent Development
Table 105. BIOTRONIK Corporation Information
Table 106. BIOTRONIK Description and Major Businesses
Table 107. BIOTRONIK Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. BIOTRONIK Product
Table 109. BIOTRONIK Recent Development
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Major Businesses
Table 112. Allergan Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Allergan Product
Table 114. Allergan Recent Development
Table 115. Bausch & Lomb Corporation Information
Table 116. Bausch & Lomb Description and Major Businesses
Table 117. Bausch & Lomb Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Bausch & Lomb Product
Table 119. Bausch & Lomb Recent Development
Table 120. REVA Medical Corporation Information
Table 121. REVA Medical Description and Major Businesses
Table 122. REVA Medical Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. REVA Medical Product
Table 124. REVA Medical Recent Development
Table 125. MicroPort Medical Corporation Information
Table 126. MicroPort Medical Description and Major Businesses
Table 127. MicroPort Medical Implantable Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. MicroPort Medical Product
Table 129. MicroPort Medical Recent Development
Table 130. Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 131. Global Implantable Drug-Eluting Devices Production Forecast by Regions (2021-2026) (K Units)
Table 132. Global Implantable Drug-Eluting Devices Production Forecast by Type (2021-2026) (K Units)
Table 133. Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 134. North America Implantable Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 135. Europe Implantable Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 136. Asia Pacific Implantable Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 137. Latin America Implantable Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 138. Middle East and Africa Implantable Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 139. Implantable Drug-Eluting Devices Distributors List
Table 140. Implantable Drug-Eluting Devices Customers List
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. Implantable Drug-Eluting Devices Product Picture
Figure 2. Global Implantable Drug-Eluting Devices Production Market Share by Type in 2020 & 2026
Figure 3. Implantable Drug Infusion Pumps Product Picture
Figure 4. Intraocular Drug-Eluting Devices Product Picture
Figure 5. Contraceptive Drug-Eluting Devices Product Picture
Figure 6. Drug-Eluting Stents Product Picture
Figure 7. Others Product Picture
Figure 8. Global Implantable Drug-Eluting Devices Consumption Market Share by Application in 2020 & 2026
Figure 9. Diabetes
Figure 10. Contraception
Figure 11. HIV/AIDS Prevention
Figure 12. Chronic Pain Management
Figure 13. Cardiovascular
Figure 14. Ophthalmology
Figure 15. Oncology
Figure 16. Others
Figure 17. Implantable Drug-Eluting Devices Report Years Considered
Figure 18. Global Implantable Drug-Eluting Devices Revenue 2015-2026 (Million US$)
Figure 19. Global Implantable Drug-Eluting Devices Production Capacity 2015-2026 (K Units)
Figure 20. Global Implantable Drug-Eluting Devices Production 2015-2026 (K Units)
Figure 21. Global Implantable Drug-Eluting Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 22. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Implantable Drug-Eluting Devices Production Share by Manufacturers in 2015
Figure 24. The Top 10 and Top 5 Players Market Share by Implantable Drug-Eluting Devices Revenue in 2019
Figure 25. Global Implantable Drug-Eluting Devices Production Market Share by Region (2015-2020)
Figure 26. Implantable Drug-Eluting Devices Production Growth Rate in North America (2015-2020) (K Units)
Figure 27. Implantable Drug-Eluting Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 28. Implantable Drug-Eluting Devices Production Growth Rate in Europe (2015-2020) (K Units)
Figure 29. Implantable Drug-Eluting Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 30. Implantable Drug-Eluting Devices Production Growth Rate in China (2015-2020) (K Units)
Figure 31. Implantable Drug-Eluting Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 32. Global Implantable Drug-Eluting Devices Consumption Market Share by Regions 2015-2020
Figure 33. North America Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. North America Implantable Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 35. North America Implantable Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 36. U.S. Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Canada Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Europe Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Europe Implantable Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 40. Europe Implantable Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 41. Germany Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. France Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. U.K. Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Italy Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Russia Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. Asia Pacific Implantable Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 47. Asia Pacific Implantable Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 48. Asia Pacific Implantable Drug-Eluting Devices Consumption Market Share by Regions in 2019
Figure 49. China Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Japan Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. South Korea Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. India Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Australia Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Taiwan Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Vietnam Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Latin America Implantable Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 61. Latin America Implantable Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 62. Latin America Implantable Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 63. Mexico Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Brazil Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Argentina Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Middle East and Africa Implantable Drug-Eluting Devices Consumption and Growth Rate (K Units)
Figure 67. Middle East and Africa Implantable Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 68. Middle East and Africa Implantable Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 69. Turkey Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 70. Saudi Arabia Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 71. U.A.E Implantable Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 72. Global Implantable Drug-Eluting Devices Production Market Share by Type (2015-2020)
Figure 73. Global Implantable Drug-Eluting Devices Production Market Share by Type in 2019
Figure 74. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
Figure 75. Global Implantable Drug-Eluting Devices Revenue Market Share by Type in 2019
Figure 76. Global Implantable Drug-Eluting Devices Production Market Share Forecast by Type (2021-2026)
Figure 77. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 78. Global Implantable Drug-Eluting Devices Market Share by Price Range (2015-2020)
Figure 79. Global Implantable Drug-Eluting Devices Consumption Market Share by Application (2015-2020)
Figure 80. Global Implantable Drug-Eluting Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 81. Global Implantable Drug-Eluting Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 82. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Surmodics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Titan Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. BIOTRONIK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Bausch & Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. REVA Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. MicroPort Medical Total Revenue (US$ Million

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group774180

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Implantable Hearing Aid Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery Based on the Implantable Hearing Aid market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy...
Global Neuromodulation Devices And Implantable Infusion Pumps Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery Based on the Neuromodulation Devices And Implantable Infusion Pumps market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and com...
Global Implantable Drug Delivery Devices Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery Implantable devices are called upon to serve a variety of functions, from vascular stents that preserve blood flow to electrostimulation devices that regulate heart rhythm or block spurious signals in the brain, to orthopedic devices that mechanicall...
Global Subcutaneous Implantable Defibrillators Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery Based on the Subcutaneous Implantable Defibrillators market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive comp...
Global Implantable Loop Recorders Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery Based on the Implantable Loop Recorders market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strat...
Covid-19 Impact on Global Implantable Drug Delivery Devices Market Size, Status and Forecast 2020-2026 Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimise side-effects whilst increasing patient compliance. BD, B.Braun, AngioDynamics, Smiths Med...
COVID-19 Impact on Global Polymers for Implantable Medical Devices Market Insights, Forecast to 2026 Implant medical device is a medical device manufactured to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure. Medical implants are man-made devices, in contrast to a transplant...
Covid-19 Impact on Global Implantable Pacing Lead Market Insights, Forecast to 2026 This is permanent implantable in the heart. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. ...
Covid-19 Impact on Global Implantable Cardiac Pacing Lead Market Insights, Forecast to 2026 This is permanent implantable in the heart. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. ...
Covid-19 Impact on Global Implantable Cardiac Rhythm Management Device Market Insights, Forecast to 2026 Implantable Cardiac Rhythm Management Devices are used for either too slow a heart rhythm (pacemakers) or too fast a rhythm (cardioverter defibrillators) help patients benefit as their overall health status can be improved. Increasing prevalen...
Covid-19 Impact on Global Implantable Venous Access Port Market Insights, Forecast to 2026 The iImplantable Venous Access Port, also known as PORT in the clinic, is a professional infusion device that is placed in the body to reduce the vascular irritation of the drug. It is divided into three parts: a non-invasive needle (butterfly needle...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *